Influence of continuous levels of fentanyl in rats on the μ-opioid receptor in the central nervous system

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 189-194

  Albrecht, Erika ^a   Heinrich, Nadja ^a   Lorenz, Dorothea ^a   Baeger, Ingo ^a   Samovilova, Nelya ^b   Fechner, Klaus ^a   Berger, Hartmut ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

opioid receptor; Adenylate cyclase; Analgesia; DAMGO binding; Fentanyl; GTP regulation; Rat; Tolerance

Indexed keywords

ADENYLATE CYCLASE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL; MU OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; DRUG URINE LEVEL; HISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENYLATE CYCLASE; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; FENTANYL; GUANOSINE TRIPHOSPHATE; MALE; MEMBRANES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; SPINAL CORD;

ANIMALIA;

EID: 0030754885     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00480-7     Document Type: Article

References (29)

1. Besse D., Lombard M. C., Besson J. M. Up-regulation of (H-3)DAMGO and (H-3)DTLET opioid binding sites in laminae I-II of the spinal cord in intact and deafferented morphine-tolerant rats. Neuroscience Lett. 136:1992;209-212.
2. Bhargava H. N., Gulati A. Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats. European J. Pharmacol. 190:1990;305-311.
3. Björkman S., Stanski D. R., Verotta D., Harashima H. Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats. Anesthesiology. 72:1990;865-873.
4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Brady L. S., Herkenham M., Long J. B., Rothman R. B. Chronic morphine increases μ-opiate receptor binding in rat brain. A quantitative autoradiographic study Brain Res. 477:1989;382-386.
6. Collin E., Poulain P., Gauvainpiquard A., Petit G., Pichardleandri E. Is disease progression the major factor in morphine tolerance in cancer pain treatment. Pain. 55:1993;319-326.
7. Cox, B. M.; Werling, L. L.: Opioid tolerance and dependence. In: Pratt, J. A., ed. The biological bases of drug tolerance and dependence. London: Academic Press, Harcourt Brace Jovanovich, Publishers; 1991:199-229.
8. De Vries T. J., Ril G. H. K. T. T., Van der Laan J. W., Mulder A. H., Schoffelmeer A. N. M. Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity. Life Sci. 52:1993;1685-1693.
9. Diaz A., Ruiz F., Florez J., Hurle M. A., Pazos A. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J. Pharmacol. Exp. Ther. 274:1995;1545-1551.
10. Duman R. S., Tallman J. F., Nestler E. J. Acute and chronic opiate-regulation of adenylate cyclase in brain. Specific effects in locus coeruleus J. Pharmacol. Exp. Ther. 246:1988;1033-1039.
11. Guitart X., Nestler E. J. Second messenger and protein phosphorylation mechanisms underlying opiate addiction - Studies in the rat locus-coeruleus. Neurochemical Res. 18:1993;5-13.
12. Hanks G. W. Pain management in cancer patients. Therapie. 47:1992;489-493.
13. Lehmann K. A., Hunger L., Brandt K., Daub D. Biotransformation von Fentanyl. III. Einflüsse chronischer Arzneimittelexposition auf Verteilung, Metabolismus und Ausscheidung bei der Ratte. Anaesthesist. 32:1983;165-173.
14. Nestler E. J., Erdos J. J., Terwilliger R., Duman R. S., Tallman J. F. Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res. 476:1989;230-239.
15. Nishino K., Su Y. F., Wong C. -S., Watkins W. D., Chang K. J. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord. J. Pharmacol. Exp. Ther. 253:1990;67-72.
16. Paronis C. A., Holtzman S. G. Development of tolerance to the analgesic activity of μ-agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther. 262:1992;1-9.
17. Rogers N. F., El-Fakahany E. E. Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells. European J. Pharmacol. 124:1986;221-230.
18. Rothman R. B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138.
19. 3H]-D-Ala2,MePhe4,Gly-ol5-enkephalin. Further evidence for two μ-binding sites European J. Pharmacol. 160:1989;71-82.
20. 3H]cycloFOXY. A novel opiate antagonist suitable for positron emission tomography Eur. J. Pharmacol. 142:1987;73-81.
21. Schneider E., Brune K. Distribution of fentanyl in rats. An autoradiographic study Naunyn-Schmiedebergs Arch. Pharmacol. 331:1985;359-363.
22. Sosnowski M., Yaksh T. L. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology. 73:1990;1141-1147.
23. Stevens C. W. Perspectives on opioid tolerance from basic research. Behavioural studies after spinal administration in rodents Cancer Surveys. 21:1994;25-47.
24. Stevens C. W., Yaksh T. L. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J. Pharmacol. Exp. Ther. 250:1989;1-8.
25. Stevens C. W., Yaksh T. L. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord. J. Pharmacol. Exp. Ther. 251:1989;216-223.
26. Tao P. -L., Law P. -Y., Loh H. H. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J. Pharmacol. Exp. Ther. 240:1987;809-816.
27. Tao P. -L., Lee C. -R., Law P. -Y., Loh H. H. The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 348:1993;504-508.
28. Werling L. L., McMahon P. N., Cox B. M. Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc. Natl. Acad. Sci. USA. 86:1989;6393-6397.
29. Winer, B. J.; Brown, D. R.; Michels, K. M.: Statistical principles in experimental design, 3rd edition; New York: McGraw-Hill, Inc. 1991.